• Japanese
  • Korean
  • Chinese
Cover Image

Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

"Global Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry" is a new report by ICD Research that analyzes how pharmaceutical industry companies' procurement expenditures, business strategies, and practices are set to change in 2013-2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable). This report gives access to category-level spending outlooks, budgets, supplier selection criteria, business challenges, and investment opportunities of leading purchase decision makers. The report also identifies the future growth of buyers and suppliers, MandA, capital expenditure, staff hiring, and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities, as well as access to information categorized by region, company type, and size.

Introduction and Landscape

Why was the report written?

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading global pharmaceutical industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global pharmaceutical industry. The report includes key topics such as global pharmaceutical industry buyer expenditure and procurement behaviours and strategies, and identifies the threats and opportunities within the global pharmaceutical industry, economic outlook trends, and business confidence within global pharmaceutical executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives' attitude and changing behaviours, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, ICD Research created this primary-research based report by gathering the opinions of multiple stakeholders in the value-chain of the global pharmaceutical industry.

What is the current market landscape and what is changing?

Executives from the global pharmaceutical industry anticipate an increase in levels of consolidation, with 61% of respondents projecting an increase in MandA activities in 2013.

What are the key drivers behind recent market changes?

The need for new product pipelines, new product acquisition, patent expiries, cost containment and credit availability have prompted companies to consolidate positions and look for merger and MandA acquisition.

What makes this report unique and essential to read?

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading global pharmaceutical industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global pharmaceutical industry. The report includes key topics such as global pharmaceutical industry buyer expenditure and procurement behaviours and strategies, and identifies the threats and opportunities within the global pharmaceutical industry, economic outlook trends, and business confidence within global pharmaceutical industry executives. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable).

Key Features and Benefits

Project industry trends and revenue growth expectations in 2013, and understand business confidence to make informed business decisions.

Drive revenues by understanding future product investment areas and key growth regions.

Uncover key challenges and opportunities, and identify the key actions required to maintain and win buyer business.

Formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spending in the future. Better promote your business by aligning your capabilities and business practices with your customer's changing needs

Secure stronger customer relationships by understanding the behaviour and changing strategies of industry buyers.

Key Market Issues

China, Brazil and India are the important emerging markets to offer growth in 2013.

'Market uncertainty', 'responding to price pressure', 'rising competition' and 'regulatory changes' are the leading business concerns for the global pharmaceutical industry in 2013.

Overall, for 2013, the average size of the annual procurement budget for global pharmaceutical industry buyer respondents is projected at US$127 million, against US$127 million in 2012 and US$110 million in 2011.

'Price', 'level of service' and 'existing relationship with supplier' are considered the most important factors for supplier selection in the global pharmaceutical industry, while 'environmental records and CSR', 'brand reputation' and 'proximity of supplier operations' are considered the least important.

While 16% of buyer respondents from the global pharmaceutical industry are willing to implement e-procurement in 2013 or beyond, 32% are already in the different stages of implementation ('partially implemented', 'completely implemented', and 'evaluation or pilot use')

Key Highlights

An analysis of revenue growth expectations by senior level respondents reveals that 62% are 'more optimistic' about their company's revenue growth in 2013.

A significant percentage of pharmaceutical manufacturing industry respondents highlighted that capital expenditure towards 'new product development', 'employee training', and 'IT infrastructure development' would increase in 2013.

The top three priorities for global pharmaceutical industry buyer respondents in 2013 are 'new products and services', 'improve operational efficiency' and 'expand in current markets'.

A total of 49% of respondents from pharmaceutical manufacturing companies, 68% of respondents from CROs and CMOs companies, and 64% of respondents from pharmaceutical industry supplier companies anticipate an increase of their current workforce in 2013.

Survey results show that respondents from the global pharmaceutical industry identified the US to offer the highest growth potential among developed countries in 2013-2014.

Table of Contents

1. Introduction

  • 1.1. What is This Report About?
  • 1.2. Definitions
  • 1.3. Methodology
  • 1.4. Profile of Survey Respondents: Global Pharmaceutical Industry
    • 1.4.1. Global pharmaceutical industry: profile of buyer respondents
    • 1.4.2. Global pharmaceutical industry: profile of supplier respondents

2. Executive Summary

3. Global Pharmaceutical Industry Dynamics

  • 3.1. Revenue Growth Projections in the Global Pharmaceutical Industry
    • 3.1.1. Revenue growth projections by company type
    • 3.1.2. Revenue growth projections by region
    • 3.1.3. Revenue growth projections by company turnover
    • 3.1.4. Global pharmaceutical industry: revenue growth expectations by senior level respondents
  • 3.2. Future Developments in Business Structure in the Global Pharmaceutical Industry
    • 3.2.1. Future developments in business structure by buyers
    • 3.2.2. Future developments in business structure by suppliers
    • 3.2.3. Future developments in business structure by region
    • 3.2.4. Future developments in business structure by company turnover
    • 3.2.5. Future developments in business structure by senior level respondents
  • 3.3. Change in Leading Company Strategies in the Global Pharmaceutical Industry
    • 3.3.1. Change in leading company strategies by buyers
    • 3.3.2. Change in leading company strategies by suppliers
    • 3.3.3. Change in leading company strategies by region
    • 3.3.4. Change in leading company strategies by company turnover
  • 3.4. Merger and Acquisition (MandA) Activity Projections in the Global Pharmaceutical Industry
    • 3.4.1. MandA activity projections by buyers
    • 3.4.2. MandA activity projections by suppliers
    • 3.4.3. MandA activity projections by region
    • 3.4.4. MandA activity projections by company turnover
    • 3.4.5. MandA activity projections by purchasing decision authority
    • 3.4.6. Global pharmaceutical industry - expand abroad Vs MandA activity projections
  • 3.5. Estimation of Capital Expenditure in the Global Pharmaceutical Industry
    • 3.5.1. Estimation of capital expenditure by buyers
    • 3.5.2. Estimation of capital expenditure by suppliers
    • 3.5.3. Estimation of capital expenditure by region
    • 3.5.4. Estimation of capital expenditure by company turnover
  • 3.6. Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry
    • 3.6.1. Planned change in staff recruitment activity by buyers
    • 3.6.2. Planned change in staff recruitment activity by suppliers
    • 3.6.3. Planned change in staff recruitment activity by region
    • 3.6.4. Planned change in staff recruitment activity by company turnover

4. Global Pharmaceutical Industry Market Growth Outlook

  • 4.1. Global Pharmaceutical Industry: Demand in Emerging Markets
    • 4.1.1. Demand in emerging markets by buyers
    • 4.1.2. Demand in emerging markets by suppliers
    • 4.1.3. Demand in emerging markets by region
    • 4.1.4. Demand in emerging markets by company turnover
  • 4.2. Global Pharmaceutical Industry - Growth Projections in Developed Countries
    • 4.2.1. Growth projections in developed countries by buyers
    • 4.2.2. Growth projections in developed countries by suppliers
    • 4.2.3. Growth projections in developed countries by region
    • 4.2.4. Growth projections in developed countries by company turnover

5. Threats and Opportunities for the Global Pharmaceutical Industry

  • 5.1. Global Pharmaceutical Industry: Leading Business Concerns for 2013-2014
    • 5.1.1. Leading business concerns for 2013-2014 by company type
    • 5.1.2. Leading business concerns for 2013-2014 by region
    • 5.1.3. Leading business concerns for 2013-2014 by company turnover
  • 5.2. Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business
    • 5.2.1. Actions to maintain and secure buyer business by buyers
    • 5.2.2. Actions to maintain and secure buyer business by region
    • 5.2.3. Actions to maintain and secure buyer business by company turnover
    • 5.2.4. Actions to maintain and secure buyer business by purchasing decision authority

6. Global Pharmaceutical Industry Buyer Expenditure Activity

  • 6.1. Annual Procurement Budgets in the Global Pharmaceutical Industry
    • 6.1.1. Revenue growth vs. procurement budget
    • 6.1.2. Annual procurement budgets by company type
    • 6.1.3. Annual procurement budgets by region
    • 6.1.4. Annual procurement budgets by company turnover
    • 6.1.5. Annual procurement budgets by senior level respondents
  • 6.2. Planned Change in Procurement Expenditure in the Global Pharmaceutical Industry
    • 6.2.1. Planned change in procurement expenditure by buyer type
    • 6.2.2. Planned change in procurement expenditure by region
    • 6.2.3. Planned change in procurement expenditure by company turnover
    • 6.2.4. Planned change in procurement expenditure vs. revenue growth optimism
    • 6.2.5. Planned change in procurement expenditure vs. cost containment
  • 6.3. Planned change in Procurement Expenditure by Product and Service Category
    • 6.3.1. Planned change in procurement expenditure by product and service category - region
    • 6.3.2. Planned change in procurement expenditure by product and service category - company turnover
  • 6.4. Global Pharmaceutical Industry: Variations in Regional Supplier Prices
    • 6.4.1. Variations in regional supplier prices by company type
    • 6.4.2. Variations in regional supplier prices by region
    • 6.4.3. Variations in regional supplier prices by company turnover

7. Global Pharmaceutical Industry: Procurement Behaviors and Strategies

  • 7.1. Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection
  • 7.2. E-procurement in the Global Pharmaceutical Industry
    • 7.2.1. E-procurement in the global pharmaceutical industry by buyer type
    • 7.2.2. E-procurement in the global pharmaceutical industry by region
    • 7.2.3. E-procurement in the global pharmaceutical industry by company turnover

8. Appendix

  • 8.1. Global Pharmaceutical Industry Survey Results- Closed Questions
  • 8.2. Methodology
  • 8.3. Contact us
  • 8.4. About ICD Research
  • 8.5. Disclaimer

List of Tables

  • Table 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013
  • Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013
  • Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013
  • Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013
  • Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013
  • Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013
  • Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013
  • Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
  • Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010-2013
  • Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010-2013
  • Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013
  • Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
  • Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
  • Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry (%), 2013
  • Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
  • Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
  • Table 21: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
  • Table 22: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
  • Table 23: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Table 24: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
  • Table 25: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
  • Table 26: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
  • Table 27: Global Pharmaceutical Industry - Expand Abroad vs. MandA Activity Projections(%), 2013
  • Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
  • Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
  • Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
  • Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013
  • Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
  • Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
  • Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
  • Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
  • Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
  • Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
  • Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
  • Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
  • Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
  • Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
  • Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Turnover (%), 2013
  • Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010-2013
  • Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
  • Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013-2014
  • Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
  • Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
  • Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013
  • Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing Decision Authority (%), 2013
  • Table 50: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010-2013
  • Table 51: Global Pharmaceutical Industry Buyers - Increase in Revenue Growth vs. Procurement Budget (%), 2013
  • Table 52: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
  • Table 53: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Region(%), 2013
  • Table 54: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
  • Table 55: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%), 2013
  • Table 56: Change in Procurement Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013
  • Table 57: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
  • Table 58: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013
  • Table 59: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%), 2013
  • Table 60: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. Revenue Growth (%), 2013
  • Table 61: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. Cost Containment (%), 2013
  • Table 62: Future Change in Expenditure by Product and Service Category, Pharmaceutical Industry Manufacturers (%), 2013
  • Table 63: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013
  • Table 64: Increase in Expenditure by Product and Service Category - Buyers by Region , 2013
  • Table 65: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013
  • Table 66: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
  • Table 67: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%), 2013
  • Table 68: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Turnover (%), 2013
  • Table 69: Critical Success Factors for Supplier Selection - Global Pharmaceutical Industry Buyers, 2013
  • Table 70: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%), 2013
  • Table 71: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013
  • Table 72: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013
  • Table 73: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2013
  • Table 74: Survey Results - Closed Questions

List of Figures

  • Figure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013
  • Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%), 2010-2013
  • Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013
  • Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013
  • Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry (%), 2013
  • Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry (%), 2013
  • Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry (%), 2013
  • Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%), 2013
  • Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%), 2013
  • Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%), 2013
  • Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%), 2013
  • Figure 13: MandA Activity Projections - Global Pharmaceutical Industry (%), 2013
  • Figure 14: MandA Activity Projections - Global Pharmaceutical Manufacturers' Industry (%), 2010-2013
  • Figure 15: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013
  • Figure 16: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013
  • Figure 17: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
  • Figure 18: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013
  • Figure 19: Global Pharmaceutical Industry MandA Activity Projections by Purchasing Decision Authority (%), 2013
  • Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs MandA Activity Projections (%), 2013
  • Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013
  • Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013
  • Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013
  • Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013
  • Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%), 2013
  • Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity (%), 2013
  • Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region (%), 2013
  • Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Turnover (%), 2013
  • Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013
  • Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013
  • Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013
  • Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013
  • Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013
  • Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013
  • Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013
  • Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013
  • Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%), 2013
  • Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%), 2013
  • Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries (%), 2013
  • Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countries by Region (%), 2013
  • Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013
  • Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013
  • Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013
  • Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013-2014
  • Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses (%), 2013
  • Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%), 2013
  • Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013
  • Figure 48: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%), 2010-2013
  • Figure 49: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Buyer Type (%), 2013
  • Figure 50: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover (%), 2013
  • Figure 51: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior Level Respondents (%), 2013
  • Figure 52: Change in Procurement Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013
  • Figure 53: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%), 2013
  • Figure 54: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013
  • Figure 55: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%), 2013
  • Figure 56: Future Change in Expenditure by Product and Service Category, Buyers , 2013
  • Figure 57: Future Change in Expenditure by Product and Service Category, Pharmaceutical Industry Manufacturers (%), 2013
  • Figure 58: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013
  • Figure 59: Increase in Expenditure by Product and Service Category - Buyers by Turnover (%), 2013
  • Figure 60: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013
  • Figure 61: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type (%), 2013
  • Figure 62: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%), 2013
  • Figure 63: Critical Success Factors for Supplier Selection - Global Pharmaceutical Industry Buyers, 2013
  • Figure 64: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%), 2013
  • Figure 65: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013
  • Figure 66: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013
  • Figure 67: E-Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2013
Show More
Pricing